Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients (MANON 02)

This study has been completed.
Information provided by:
Objectif Recherche Vaccins SIDA Identifier:
First received: September 16, 2005
Last updated: November 24, 2009
Last verified: November 2009